Carregant...
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia
Children with immune thrombocytopenia for ≥6 months completing a romiplostim study received weekly subcutaneous romiplostim (1-10 μg/kg targeting platelet counts of 50-200×10(9)/L) in this extension to examine romiplostim’s long-term safety and efficacy. Sixty-five children received romiplostim for...
Guardat en:
| Publicat a: | Haematologica |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821612/ https://ncbi.nlm.nih.gov/pubmed/30846500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.202283 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|